doi: 10.1164/rccm.202406-1206RL.
Response Bias for Modified Borg 0-10 Numerical Categories without Verbal Descriptors during Assessment of Exertional Symptoms
Collaborators,
Affiliations
- PMID: 39514843
- DOI: 10.1164/rccm.202406-1206RL
Item in Clipboard
Response Bias for Modified Borg 0-10 Numerical Categories without Verbal Descriptors during Assessment of Exertional Symptoms
Am J Respir Crit Care Med.
2025 Feb.
No abstract available
Publication types
Grants and funding
- Almirall/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- AstraZeneca Canada Ltd./CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Boehringer Ingelheim Canada Ltd./CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Canadian Institutes of Health Research [CIHR/Rx&D/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Canadian Respiratory Research Network/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Foundation of the McGill University Health Centre/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- GlaxoSmithKline (GSK) Canada Ltd./CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Merck/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Novartis/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Nycomed/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Pfizer Canada Ltd./CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Respiratory Health Research Network of the Fonds d/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- Theratechnologies/CanCOLD study (ClinicalTrials.gov Identifier: NCT00920348)/United States
- ME has received a research grant from ResMed./ResMed Foundation/United States
- ME has received personal fees from AstraZeneca Ltd/ResMed Foundation/United States
- ME has received personal fees from Boehringer Inge/ResMed Foundation/United States
- ME has received personal fees from Novartis./ResMed Foundation/United States
- ME has received personal fees from Roche./ResMed Foundation/United States
- RA is supported by a doctoral scholarship from FRQ/Fonds de Recherche du Québec - Santé/United States
- DJ holds a Canada Research Chair Tier II/Canadian Institute of Health Research/United States
LinkOut - more resources
Full Text Sources
